全文获取类型
收费全文 | 1581篇 |
免费 | 124篇 |
出版年
2022年 | 17篇 |
2021年 | 18篇 |
2020年 | 13篇 |
2019年 | 19篇 |
2018年 | 26篇 |
2017年 | 24篇 |
2016年 | 43篇 |
2015年 | 55篇 |
2014年 | 61篇 |
2013年 | 80篇 |
2012年 | 94篇 |
2011年 | 101篇 |
2010年 | 69篇 |
2009年 | 64篇 |
2008年 | 71篇 |
2007年 | 85篇 |
2006年 | 86篇 |
2005年 | 68篇 |
2004年 | 71篇 |
2003年 | 56篇 |
2002年 | 70篇 |
2001年 | 34篇 |
2000年 | 23篇 |
1999年 | 29篇 |
1998年 | 18篇 |
1997年 | 22篇 |
1996年 | 23篇 |
1995年 | 15篇 |
1994年 | 11篇 |
1993年 | 19篇 |
1992年 | 14篇 |
1991年 | 11篇 |
1990年 | 15篇 |
1989年 | 13篇 |
1987年 | 14篇 |
1985年 | 16篇 |
1984年 | 11篇 |
1983年 | 14篇 |
1981年 | 11篇 |
1980年 | 11篇 |
1979年 | 8篇 |
1977年 | 13篇 |
1976年 | 10篇 |
1974年 | 7篇 |
1972年 | 10篇 |
1969年 | 12篇 |
1968年 | 9篇 |
1967年 | 11篇 |
1962年 | 7篇 |
1961年 | 7篇 |
排序方式: 共有1705条查询结果,搜索用时 281 毫秒
201.
202.
Oliveira AV Gaspar AR Francisco SC Quintela DA 《International journal of biometeorology》2012,56(2):319-332
The present experimental work is dedicated to the analysis of the effect of walking on the thermal insulation of the air layer
(I
a
) and on the convective heat transfer coefficients (h
conv
) of the human body. Beyond the standing static posture, three step rates were considered: 20, 30 and 45 steps/min. This corresponds
to walking speeds of approximately 0.23, 0.34 and 0.51 m/s, respectively. The experiments took place in a climate chamber
with an articulated thermal manikin with 16 independent parts. The indoor environment was controlled through the inner wall
temperatures since the objective of the tests was restricted to the influence of the walking movements under calm conditions.
Five set points were selected: 10, 15, 20, 25 and 30°C, and the operative temperature within the test chamber varied between
11.9 and 29.6°C. The highest and lowest I
a
values obtained were equal to 0.87 and 0.71 clo, respectively, and the reduction in insulation due to walking ranged between
9.8 and 11.5%. The convective coefficients (h
conv
) for the whole body and for the different body segments were also determined for each step rate. In the case of the whole
body, for the standing static reference posture, the mean value of h
conv
was equal to 3.3 W/m2°C and a correlation [Nu = Nu(Gr)] for natural convection is also presented in good agreement with previous results. For the other postures, the values of
h
conv
were equal to 3.7, 3.9 and 4.2 W/m2°C, respectively for 20, 30 and 45 steps/min. 相似文献
203.
204.
While it has long been understood that CD40 plays a critical role in the etiology of autoimmunity, glycobiology is emerging as an important contributor. CD40 signaling is also gaining further interest in transplantation and cancer therapies. Work on CD40 signaling has focused on signaling outcomes and blocking of its ligand, CD154, while little is known about the actual receptor itself and its control. We demonstrated that CD40 is in fact several receptors occurring as constellations of differentially glycosylated forms of the protein that can sometimes form hybrid receptors with other proteins. An enticing area of autoimmunity is differential glycosylation of immune molecules leading to altered signaling. Galectins interact with carbohydrates on proteins to effect such signaling alterations. Studying autoimmune prone NOD and non-autoimmune BALB/c mice, here we reveal that in-vivo CD40 signals alter the glycosylation status of non-autoimmune derived CD4 T cells to resemble that of autoimmune derived CD4 T cells. Galectin-9 interacts with CD40 and, at higher concentrations, prevents CD40 induced proliferative responses of CD4(lo)CD40(+) effector T cells and induces cell death through a Tim-3 independent mechanism. Interestingly, galectin-9, at lower concentrations, alters the surface expression of CD3, CD4, and TCR, regulating access to those molecules and thereby redirects the inflammatory cytokine phenotype and CD3 induced proliferation of autoimmune CD4(lo)CD40(+) T cells. Understanding the dynamics of the CD40 receptor(s) and the impact of glycosylation status in immunity will gain insight into how to maintain useful CD40 signals while shutting down detrimental ones. 相似文献
205.
Elsaesser O Leiter U Buettner PG Eigentler TK Meier F Weide B Metzler G Breuninger H Garbe C 《PloS one》2012,7(1):e29791
Background
This study investigated survival probabilities and prognostic factors in sentinel lymph node biopsy (SLNB) staged patients with cutaneous melanoma (CM) with the aim of defining subgroups of patients who are at higher risk for recurrences and who should be considered for adjuvant clinical trials.Methods
Patients with primary CM who underwent SLNB in the Department of Dermatology, University of Tuebingen, Germany, between 1996 and 2009 were included into this study. Survival probabilities and prognostic factors were evaluated by Kaplan-Meier and multivariate Cox proportional hazard models.Results
1909 SLNB staged patients were evaluated. Median follow-up time was 44 months. Median tumor thickness was 1.8 mm, ulceration was present in 31.8% of cases. The 5-year Overall Survival (OS) was 90.3% in SLNB negative patients (IB 96.2%, IIA 87.0%, IIB 78.1%, IIC 72.6%). Patients with micrometastases (stage IIIA/B) had a 5-year OS rate of 70.9% which was clearly less favorable than for stages I–II. Multivariate analysis revealed tumor thickness, ulceration, body site, histopathologic subtype and SLNB status as independent significant prognostic factors.Conclusion
Survival rates of patients with primary CM in stages I–II were shown to be much more favorable than previously reported from non sentinel node staged collectives. For future clinical trials, sample size calculations should be adapted using survival probabilities based on sentinel node staging. 相似文献206.
Gisela N. Castro Niubys Cayado-Gutiérrez Vera L. Moncalero Patricia Lima Rodolfo Lucero De Angelis Victor Chávez F. Darío Cuello-Carrión Daniel R. Ciocca 《Cell stress & chaperones》2012,17(6):779-790
In oligodendrogliomas, 1p loss of heterozygosity (LOH) is a predictor of good prognosis and treatment response. In contrast, in uveal melanomas, LOH of chromosome 3 has been linked to poor prognosis and downregulation of Hsp27. In the present study, we have analyzed the expression of heat-shock proteins (Hsps) to characterize subtypes of gliomas and their histopathologic features and to correlate with other molecular markers including LOH of 1p. Biopsies from patients with primary gliomas (n = 65) were analyzed by immunohistochemistry, chromogenic in situ hybridization and fluorescent in situ hybridization and methylation-specific PCR (MSP). Elevated Hsp27 and total Hsp70 expression levels were associated with high-grade astrocytomas (p = 0.0001 and p = 0.01, respectively). In grade III oligodendrogliomas, the Hsp27 levels were significantly higher (p = 0.03). Low O6-methylguanine-DNA methyltransferase (MGMT) expression was associated with grade II astrocytomas. Elevated β-catenin expression was associated with grade III/IV astrocytomas (p = 0.003); p53 (+) tumors were more frequently found in grade III/IV astrocytomas (p = 0,001). LOH on 1p was associated with oligodendroglial tumours. In addition, a higher Hsp27 expression correlated with LOH of 1p (p = 0.017); this was also tested in two glioma cell lines. MSP was successful in only six samples. No significant correlations were found for the other markers. In conclusion, in oligodendroglial tumors, Hsp27 appeared as a surrogate marker of LOH of 1p which could also help to predict the disease prognosis. In gliomas, p53, Hsp27, Hsp70, MGMT, and β-catenin correlated with histopathological characteristics, suggesting that these markers could predict the disease outcome and the response to treatments. 相似文献
207.
208.
209.
Fernandes AS Costa J Gaspar J Rueff J Cabral MF Cipriano M Castro M Oliveira NG 《Free radical research》2012,46(9):1157-1166
The unique redox and catalytic chemistry of Cu has justified the development of novel Cu complexes for different therapeutic uses including cancer therapy. In this work, four pyridine-containing aza-macrocyclic copper(II) complexes were prepared (CuL1-CuL4) varying in ring size and/or substituents and their superoxide scavenging activity evaluated. CuL3, the most active superoxide scavenger, was further studied as a modulator of the cytotoxicity of oxaliplatin in epithelial breast MCF10A cells and in MCF7 breast cancer cells. Our results show that CuL3 enhances the therapeutic window of oxaliplatin, by both protecting non-tumour cells and increasing its cytotoxic effect in breast carcinoma cells. CuL3 is thus a promising complex to be further studied and to be used as a lead compound for the optimization of novel chemotherapy sensitizers. 相似文献
210.
L Bauer R Langer K Becker A Hapfelmeier K Ott A Novotny H Höfler G Keller 《PloS one》2012,7(9):e44566
Cancer stem cell (CSC) based gene expression signatures are associated with prognosis in various tumour types and CSCs are suggested to be particularly drug resistant. The aim of our study was first, to determine the prognostic significance of CSC-related gene expression in residual tumour cells of neoadjuvant-treated gastric cancer (GC) patients. Second, we wished to examine, whether expression alterations between pre- and post-therapeutic tumour samples exist, consistent with an enrichment of drug resistant tumour cells. The expression of 44 genes was analysed in 63 formalin-fixed, paraffin embedded tumour specimens with partial tumour regression (10-50% residual tumour) after neoadjuvant chemotherapy by quantitative real time PCR low-density arrays. A signature of combined GSK3B(high), β-catenin (CTNNB1)(high) and NOTCH2(low) expression was strongly correlated with better patient survival (p<0.001). A prognostic relevance of these genes was also found analysing publically available gene expression data. The expression of 9 genes was compared between pre-therapeutic biopsies and post-therapeutic resected specimens. A significant post-therapeutic increase in NOTCH2, LGR5 and POU5F1 expression was found in tumours with different tumour regression grades. No significant alterations were observed for GSK3B and CTNNB1. Immunohistochemical analysis demonstrated a chemotherapy-associated increase in the intensity of NOTCH2 staining, but not in the percentage of NOTCH2. Taken together, the GSK3B, CTNNB1 and NOTCH2 expression signature is a novel, promising prognostic parameter for GC. The results of the differential expression analysis indicate a prominent role for NOTCH2 and chemotherapy resistance in GC, which seems to be related to an effect of the drugs on NOTCH2 expression rather than to an enrichment of NOTCH2 expressing tumour cells. 相似文献